Studies related to and

Prolonged-release Melatonin Improves Sleep Quality And Morning Alertness In Insomnia Patients Aged 55 Years And Older And Has No Withdrawal Effects

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 170
Gender n/a
Notes for this study:
In primary insomnia patients, 2mg of prolonged release melatonin was effective in reducing sleep latency (time to sleep) and improving sleep quality without withdrawal effects.

Full details on all 4 studies are available to Examine Plus members.

Already a member? Login now to access.